Barletta C, Di Natale V, Esposito M, Chisari M, Cocimano G, Di Mauro L
Int J Mol Sci. 2025; 26(2).
PMID: 39859160
PMC: 11765396.
DOI: 10.3390/ijms26020444.
Bufanda L, Montoya A, Carrillo B, Tejeda M, Segovia L, Calderon-Villarreal A
Harm Reduct J. 2025; 22(1):2.
PMID: 39755636
PMC: 11699760.
DOI: 10.1186/s12954-024-01143-2.
Miller T, Mathews J, Dungan G, Pergolizzi J, Raffa R
Cureus. 2024; 16(11):e74826.
PMID: 39618763
PMC: 11608063.
DOI: 10.7759/cureus.74826.
Vinnikov A, Sheppard C, Wemple A, Stern J, Leopold M
Micromachines (Basel). 2024; 15(11).
PMID: 39597161
PMC: 11596286.
DOI: 10.3390/mi15111340.
Stern J, Wemple A, Sheppard C, Vinnikov A, Leopold M
Toxics. 2024; 12(11).
PMID: 39590971
PMC: 11598047.
DOI: 10.3390/toxics12110791.
Xylazine-Associated Wounds of the Upper Extremity: Evaluation and Algorithmic Surgical Strategy.
Tosti R, Hozack B, Tulipan J, Criner-Woozley K, Ilyas A
J Hand Surg Glob Online. 2024; 6(5):605-609.
PMID: 39381381
PMC: 11456669.
DOI: 10.1016/j.jhsg.2024.05.003.
Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021.
Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F
Drug Alcohol Depend. 2024; 263:111419.
PMID: 39216201
PMC: 11684856.
DOI: 10.1016/j.drugalcdep.2024.111419.
Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration.
Eger W, Plesons M, Bartholomew T, Bazzi A, Hauschild M, McElrath C
Harm Reduct J. 2024; 21(1):162.
PMID: 39210359
PMC: 11363649.
DOI: 10.1186/s12954-024-01082-y.
Protective or potentially harmful? Altering drug consumption behaviors in response to xylazine adulteration.
Eger W, Plesons M, Bartholomew T, Bazzi A, Hauschild M, McElrath C
Res Sq. 2024; .
PMID: 39149447
PMC: 11326414.
DOI: 10.21203/rs.3.rs-4810429/v1.
Xylazine in illicit drug mixtures: a growing threat and overlooked danger.
Habib A, Ali T, Fatima L, Nazir Z, Hafiz A, Haque M
Ann Med Surg (Lond). 2024; 86(7):3816-3819.
PMID: 38989224
PMC: 11230776.
DOI: 10.1097/MS9.0000000000002190.
Opioid crisis: compound opens up potential strategy to tackle overdoses.
Cahill C
Nature. 2024; 631(8021):512-513.
PMID: 38961206
DOI: 10.1038/d41586-024-02133-x.
Functionalized Gold Nanoparticles and Halogen Bonding Interactions Involving Fentanyl and Fentanyl Derivatives.
Sherard M, Kaplan J, Simpson J, Kittredge K, Leopold M
Nanomaterials (Basel). 2024; 14(11).
PMID: 38869542
PMC: 11173406.
DOI: 10.3390/nano14110917.
"Tranq-dope" overdose and mortality: lethality induced by fentanyl and xylazine.
Smith M, Biancorosso S, Camp J, Hailu S, Johansen A, Morris M
Front Pharmacol. 2023; 14:1280289.
PMID: 37954845
PMC: 10637371.
DOI: 10.3389/fphar.2023.1280289.